logo

For the Inventor, By the Inventor

Newburyport, MA, United States of America

Aine Quimby

This inventor holds 14 USPTO granted patents and 8 published patent applications. Top assignee: Abclonal Science, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aine Quimby. Retrieved from https://idiyas.com/inventor/aine-quimby-40oll6eb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 85.7

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal14 out of 23 
 
Abclonal Science, Inc.
 patents

Years Active: 2021-2026

Loading Chart...
14 patents (USPTO):Explore Patents
1. 12644112 - T7 DNA Ligase Variants with Increased Ligation Activity (2026-06-02),
2. 12630813 - TEV Protease with Dual Affinity Tags (2026-05-19),
3. 12435319 - Double tagged Serratia Marcescens nuclease (2025-10-07),
4. 12428630 - Taq DNA polymerase variants with increased reverse transcriptase activity (2025-09-30),
5. 12416044 - T4 DNA ligase variants with increased ligation efficiency (2025-09-16),
6. 12359185 - T4 DNA ligase variants with increased resistance to salt (2025-07-15),
7. 12247191 - Adjustable plate holder for cell cultures (2025-03-11),
8. 12091686 - Process of probe qPCR using Taq DNA polymerase mutants (2024-09-17),
9. 11788082 - T4 DNA ligase variants with increased thermostability (2023-10-17),
10. 11781126 - Using proteases to control star activity of restriction enzymes (2023-10-10),
11. 11685913 - T4 DNA ligase variants with increased resistance to salt (2023-06-27),
12. 11649441 - Taq DNA polymerase mutants for probe qPCR (2023-05-16),
13. 11512296 - Using proteases to control restriction enzyme activity (2022-11-29),
14. 10947518 - Using proteases to control restriction enzyme activity (2021-03-16),

Title: Aine Quimby: Innovator in Nuclease Engineering and DNA Polymerase Variants

Introduction

Aine Quimby is a prominent inventor based in Newburyport, MA (US), known for her significant contributions to the field of molecular biology. With a total of 14 patents to her name, she has made remarkable advancements in the engineering of nucleases and DNA polymerases.

Latest Patents

Among her latest patents is the development of a double tagged Serratia Marcescens nuclease. This engineered nuclease displays a C-terminal Chitin Binding Domain (CBD-tag) followed by a poly-histidine tag (His-tag). This innovative design allows for easy removal from reaction solutions after nucleic acid digestion. Another notable patent involves Taq DNA polymerase variants that exhibit increased reverse transcriptase activity. These engineered variants can produce robust cDNA from RNA substrates without the need for added reverse transcriptase enzymes.

Career Highlights

Aine Quimby currently works at Abclonal Science, Inc., where she continues to push the boundaries of molecular biology research. Her work has been instrumental in enhancing the efficiency of nucleic acid manipulation techniques, which are crucial for various applications in biotechnology and medicine.

Collaborations

Throughout her career, Aine has collaborated with esteemed colleagues, including Zhenyu Zhu and Dapeng Sun. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.

Conclusion

Aine Quimby stands out as a leading inventor in the field of molecular biology, with her patents reflecting her dedication to advancing scientific knowledge. Her contributions continue to impact the industry positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…